Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Shenzhen Commits 3.5 Billion RMB for Biotech Development

publication date: Sep 29, 2009
Shenzhen has adopted a Biotech Industry Development Plan (2009-2015) that includes a commitment to invest 500 million RMB ($73.5 million) annually for the seven-year duration of the plan. The goal is to make Shenzhen a leading biotechnology center. The specific goals for the plan include helping to build three major biotech companies whose revenues will total more than 10 billion RMB ($1.5 billion), and developing five innovative drugs with worldwide patents. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital